Early gathering of patient feedback on trial technology platforms is critical to warding off potential problems during a trial. One WCG expert outlines a number of important factors to consider early in development to ensure trials employ technology with patients in mind.
Screening, initial appointment logistics and first visits are the most frustrating trial processes for site staff, according to a new study on the burdens of critical processes and decentralized trial (DCT) methodologies that interviewed a select group of CRCs about their perspectives. Read More
Electronic informed consent (eConsent) appears to be just as easy, if not easier, for patients to use and understand as traditional paper-based consenting and improves consent document completion, a recently published study has found. Experts say these findings should give sites greater confidence in taking on eConsent solutions. Read More
Protocol complexity continues to grow, the latest data show, as sponsors seek more — and more specific — data, resulting in slower trials and overburdened sites and raising a crucial question: How do sites and sponsors simplify trials without sacrificing scientific progress? Read More
The FDA has made it clear sponsors should start now to develop diversity action plans with the help not only of guidance released last year but also the promise of more guidance to come and the offer of consultation with the agency itself. Read More
Healthcare workers’ levels of stress rose to a new high of more than 40 percent in 2022, putting them at greater risk of health and work performance issues, according to the latest in a series of annual surveys. Read More
Following a request for information by the White House’s Office of Science and Technology Policy (OSTP), a number of industry groups offered suggestions for priming the U.S. clinical research infrastructure to effectively respond to future public health emergencies. Read More
Recruitment and retention plans will always be molded by the specific trial and population involved; putting careful thought into who your trial’s target participant is can help bolster enrollment/retention numbers, an expert advises. Read More
Using trial participant diversity as its roadmap, one site network has taken decentralization to its farthest limit by operating solely as a fleet of “sites on wheels” to serve communities that have little to no access to clinical trials.
Despite sites calling for a reduction in the amount of burdensome protocol amendments from sponsors, a newly published study shows that the prevalence and average number of amendments are still on the rise. Read More